Animal models for diabetes: Understanding the pathogenesis and finding new treatments

Biochemical Pharmacology

Volumn 99, Issue , 2016, Pages 1-10

  King, Aileen ^a   Bowe, James ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ALLOXAN; INSULIN; STREPTOZOCIN; ANTIDIABETIC AGENT;

AKITA MOUSE; AUTOIMMUNE DISEASE; BIOBREEDING DIABETES PRONE RAT; BIOBREEDING RAT; DIABETOGENESIS; DIET INDUCED OBESITY; EXPERIMENTAL DIABETES MELLITUS; GENETIC ASSOCIATION; GENETIC MANIPULATION; GOTO KAKIZAKI RAT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NEWBORN; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PRIORITY JOURNAL; REVIEW; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; OBESITY; PHYSIOLOGY; RISK REDUCTION; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; OBESITY; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84951819685     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.08.108     Document Type: Note

References (186)

1. J.A. Bluestone, K. Herold, and G. Eisenbarth Genetics, pathogenesis and clinical interventions in type 1 diabetes Nature 464 2010 1293 1300
2. H.K. Akerblom, and M. Knip Putative environmental factors in Type 1 diabetes Diabetes Metab. Rev. 14 1998 31 68
3. S.E. Kahn The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes Diabetologia 46 2003 3 19
4. O. Ali Genetics of type 2 diabetes World J. Diabetes 4 2013 114 123
5. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, and et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 344 2001 1343 1350
6. A. Pisania, G.C. Weir, J.J. O'Neil, A. Omer, V. Tchipashvili, J. Lei, and et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations Lab. Invest. 90 2010 1661 1675
7. N. Wierup, F. Sundler, and R.S. Heller The islet ghrelin cell J. Mol. Endocrinol. 52 2014 R35 R49
8. M.L. Campbell-Thompson, M.A. Atkinson, A.E. Butler, N.M. Chapman, G. Frisk, R. Gianani, and et al. The diagnosis of insulitis in human type 1 diabetes Diabetologia 56 2013 2541 2543
9. S. Makino, K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino Breeding of a non-obese, diabetic strain of mice Jikken dobutsu Exp. Anim. 29 1980 1 13
10. A.F. Nakhooda, A.A. Like, C.I. Chappel, F.T. Murray, and E.B. Marliss The spontaneously diabetic Wistar rat: metabolic and morphologic studies Diabetes 26 1977 100 112
11. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia Diabetes 40 1991 1375 1381
12. S. Lenzen, M. Tiedge, M. Elsner, S. Lortz, H. Weiss, A. Jorns, and et al. The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus Diabetologia 44 2001 1189 1196
13. T. Izumi, H. Yokota-Hashimoto, S. Zhao, J. Wang, P.A. Halban, and T. Takeuchi Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse Diabetes 52 2003 409 416
14. P. Pozzilli, A. Signore, A.J. Williams, and P.E. Beales NOD mouse colonies around the world - recent facts and figures Immunol. Today 14 1993 193 196
15. T. Hanafusa, J. Miyagawa, H. Nakajima, K. Tomita, M. Kuwajima, Y. Matsuzawa, and et al. The NOD mouse Diabetes Res. Clin. Pract. 24 Suppl 1994 S307 S311
16. A. Jayasimhan, K.P. Mansour, and R.M. Slattery Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse Clin. Sci. 126 2014 1 18
17. O.S. Burren, E.C. Adlem, P. Achuthan, M. Christensen, R.M. Coulson, and J.A. Todd T1DBase: update, organization and presentation of large-scale data sets for type 1 diabetes research Nucl. Acids Res. 39 2011 D997 D1001
18. J.P. Driver, Y.G. Chen, and C.E. Mathews Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes Rev. Diabet. Stud. 9 2012 169 187
19. J.P. Driver, D.V. Serreze, and Y.G. Chen Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease Semin. Immunopathol. 33 2011 67 87
20. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, and et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506 511
21. P. In't Veld Insulitis in human type 1 diabetes: a comparison between patients and animal models Semin. Immunopathol. 36 2014 569 579
22. A.K. Foulis, C.N. Liddle, M.A. Farquharson, J.A. Richmond, and R.S. Weir The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 29 1986 267 274
23. J.C. Reed, and K.C. Herold Thinking bedside at the bench: the NOD mouse model of T1DM Nat. Rev. Endocrinol. 11 2015 308 314
24. E.H. Leiter The NOD mouse: a model for analyzing the interplay between heredity and environment in development of autoimmune disease ILAR J. 35 1993 4 14
25. D. Hober, and P. Sauter Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host Nat. Rev. Endocrinol. 6 2010 279 289
26. K.C. Herold, S.E. Gitelman, M.R. Ehlers, P.A. Gottlieb, C.J. Greenbaum, W. Hagopian, and et al. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders Diabetes 62 2013 3766 3774
27. C.E. Mathews Utility of murine models for the study of spontaneous autoimmune type 1 diabetes Pediatr. Diabetes 6 2005 165 177
28. R. Bortell, and C. Yang The BB rat as a model of human type 1 diabetes Methods Mol. Biol. 933 2012 31 44
29. H.J. Jacob, A. Pettersson, D. Wilson, Y. Mao, A. Lernmark, and E.S. Lander Genetic dissection of autoimmune type I diabetes in the BB rat Nat. Genet. 2 1992 56 60
30. M.E. Elder, and N.K. Maclaren Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat J. Immunol. 130 1983 1723 1731
31. A.A. Like, E. Kislauskis, R.R. Williams, and A.A. Rossini Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat Science 216 1982 644 646
32. A.A. Like, A.A. Rossini, D.L. Guberski, M.C. Appel, and R.M. Williams Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes Science 206 1979 1421 1423
33. H. Groen, F. Klatter, J. Pater, P. Nieuwenhuis, and J. Rozing Temporary, but essential requirement of CD8+ T cells early in the pathogenesis of diabetes in BB rats as revealed by thymectomy and CD8 depletion Clin. Dev. Immunol. 10 2003 141 151
34. A.A. Like, V. Dirodi, S. Thomas, D.L. Guberski, and A.A. Rossini Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A Am. J. Pathol. 117 1984 92 97
35. C.F. Gotfredsen, K. Buschard, and E.K. Frandsen Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals Diabetologia 28 1985 933 935
36. F.W. Scott, H.E. Cloutier, R. Kleemann, U. Woerz-Pagenstert, P. Rowsell, H.W. Modler, and et al. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells Diabetes 46 1997 589 598
37. A.M. Posselt, A. Naji, J.H. Roark, J.F. Markmann, and C.F. Barker Intrathymic islet transplantation in the spontaneously diabetic BB rat Ann. Surg. 214 1991 363 371 discussion 71-73
38. A.J. Kruger, C. Yang, K.L. Lipson, S.C. Pino, J.H. Leif, C.M. Hogan, and et al. Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats Autoimmunity 44 2011 137 148
39. C. Yang, A. Jurczyk, P. diIorio, E. Norowski, M.A. Brehm, C.W. Grant, and et al. Salicylate prevents virus-induced type 1 diabetes in the BBDR rat PLoS One 8 2013 e78050
40. A. Jorns, A. Gunther, H.J. Hedrich, D. Wedekind, M. Tiedge, and S. Lenzen Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat Diabetes 54 2005 2041 2052
41. A. Jorns, B. Kubat, M. Tiedge, D. Wedekind, H.J. Hedrich, G. Kloppel, and et al. Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm- iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus Virchows Arch. 444 2004 183 189
42. A. Jorns, K.J. Rath, T. Terbish, T. Arndt, A. Meyer Zu Vilsendorf, D. Wedekind, and et al. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation Endocrinology 151 2010 3555 3565
43. J. Popovic, K.L. Kover, and W.V. Moore The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat Pediatr. Diabetes 5 2004 3 9
44. T. Maki, R. Gottschalk, and A.P. Monaco Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice Transplantation 74 2002 1684 1686
45. K. Komeda, M. Noda, K. Terao, N. Kuzuya, M. Kanazawa, and Y. Kanazawa Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats Endocr. J. 45 1998 737 744
46. J.P. Mordes, R. Bortell, E.P. Blankenhorn, A.A. Rossini, and D.L. Greiner Rat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR J. 45 2004 278 291
47. N. Yokoi, S. Hidaka, S. Tanabe, M. Ohya, M. Ishima, Y. Takagi, and et al. Role of major histocompatibility complex class II in the development of autoimmune type 1 diabetes and thyroiditis in rats Genes Immun. 13 2012 139 145
48. N. Yokoi, C. Hayashi, Y. Fujiwara, H.Y. Wang, and S. Seino Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat Diabetes 56 2007 506 512
49. N. Yokoi, K. Komeda, H.Y. Wang, H. Yano, K. Kitada, Y. Saitoh, and et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus Nat. Genet. 31 2002 391 394
50. N. Yokoi, Y. Fujiwara, H.Y. Wang, M. Kitao, C. Hayashi, T. Someya, and et al. Identification and functional analysis of CBLB mutations in type 1 diabetes Biochem. Biophys. Res. Commun. 368 2008 37 42
51. R. Spolski, M. Kashyap, C. Robinson, Z. Yu, and W.J. Leonard IL-21 signaling is critical for the development of type I diabetes in the NOD mouse Proc. Natl. Acad. Sci. U. S. A. 105 2008 14028 14033
52. T.C. Brodnicki, F. Quirk, and G. Morahan A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice Diabetes 52 2003 218 222
53. B. Krishnamurthy, J. Chee, G. Jhala, P. Trivedi, T. Catterall, C. Selck, and et al. Bim deficiency protects NOD mice from diabetes by diverting thymocytes to regulatory T cells Diabetes 2015
54. D. Dubois-Lafforgue, L. Mogenet, K. Thebault, J. Jami, P. Krief, and C. Boitard Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes Diabetes 51 Suppl. 3 2002 S489 S493
55. K.R. Simpfendorfer, R.A. Strugnell, T.C. Brodnicki, and O.L. Wijburg Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a hitchhiking interval that refines the genetic effect of Idd5.4 PLoS One 10 2015 10.1371/journal.pone.0121979
56. M.L. Lukic, S. Stosic-Grujicic, and A. Shahin Effector mechanisms in low-dose streptozotocin-induced diabetes Dev. Immunol. 6 1998 119 128
57. A. Citro, A. Valle, E. Cantarelli, A. Mercalli, S. Pellegrini, D. Liberati, and et al. CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice Diabetes 64 2015 1329 1340
58. M. Flodstrom, B. Tyrberg, D.L. Eizirik, and S. Sandler Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes Diabetes 48 1999 706 713
59. E. Cantarelli, A. Citro, S. Marzorati, R. Melzi, M. Scavini, and L. Piemonti Murine animal models for preclinical islet transplantation: no model fits all (research purposes) Islets 5 2013 79 86
60. A. Jorns, U.G. Ertekin, T. Arndt, T. Terbish, D. Wedekind, and S. Lenzen TNF-alpha antibody therapy in combination with the T-cell specific antibody anti-TCR reverses the diabetic metabolic state in the LEW.1AR1-iddm rat Diabetes 60 2015 2880 2891
61. A. Jorns, M. Akin, T. Arndt, T. Terbish, A.M. Zu Vilsendorf, D. Wedekind, and et al. Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by beta cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes J. Mol. Med. 92 2014 743 755
62. R. Abdi, R. Moore, S. Sakai, C.B. Donnelly, M. Mounayar, and R. Sackstein HCELL expression on murine MSC licenses pancreatotropism and confers durable reversal of autoimmune diabetes in NOD mice Stem Cells 33 2015 1523 1531
63. W.L. Suarez-Pinzon, G.S. Cembrowski, and A. Rabinovitch Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice Diabetologia 52 2009 1680 1682
64. R.D. Molano, A. Pileggi, T. Berney, R. Poggioli, E. Zahr, R. Oliver, and et al. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody Transplantation 75 2003 1812 1819
65. W.E. Dugoni Jr., and S.T. Bartlett Evidence that cyclosporine prevents rejection and recurrent diabetes in pancreatic transplants in the BB rat Transplantation 49 1990 845 848
66. K.L. Kover, Z. Geng, D.M. Hess, C.D. Benjamin, and W.V. Moore Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat Diabetes 49 2000 1666 1670
67. S.A. Nanji, W.W. Hancock, B. Luo, C.D. Schur, R.L. Pawlick, L.F. Zhu, and et al. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse Diabetes 55 2006 27 33
68. S. Bohman, and A.J. King Islet alpha cell number is maintained in microencapsulated islet transplantation Biochem. Biophys. Res. Commun. 377 2008 729 733
69. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 2001 537 546
70. S. Sandler, and I. Swenne Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro Diabetologia 25 1983 444 447
71. K. Srinivasan, and P. Ramarao Animal models in type 2 diabetes research: an overview Indian J. Med. Res. 125 2007 451 472
72. Y. Dekel, Y. Glucksam, I. Elron-Gross, and R. Margalit Insights into modeling streptozotocin-induced diabetes in ICR mice Lab. Anim. 38 2009 55 60
73. K. Hayashi, R. Kojima, and M. Ito Strain differences in the diabetogenic activity of streptozotocin in mice Biol. Pharm. Bull. 29 2006 1110 1119
74. J. Nerup, T. Mandrup-Poulsen, S. Helqvist, H.U. Andersen, F. Pociot, J.I. Reimers, and et al. On the pathogenesis of IDDM Diabetologia 37 Suppl. 2 1994 S82 S89
75. C.L. Rackham, P.K. Dhadda, P.C. Chagastelles, S.J. Simpson, A.A. Dattani, J.E. Bowe, and et al. Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice Cytotherapy 15 2013 449 459
76. C.L. Rackham, P.M. Jones, and A.J. King Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice PLoS One 8 2013 e57844
77. A. King, J. Lau, A. Nordin, S. Sandler, and A. Andersson The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets Diabetes Technol. Ther. 5 2003 653 663
78. R. Krishnan, B. Buder, M. Alexander, C.E. Foster 3rd, and J.R. Lakey Juvenile porcine islets can restore euglycemia in diabetic athymic nude mice after xenotransplantation Transplantation 99 2015 710 716
79. E.J. Grossman, D.D. Lee, J. Tao, R.A. Wilson, S.Y. Park, G.I. Bell, and et al. Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice PLoS One 5 2010 e8749
80. C.L. Rackham, P.C. Chagastelles, N.B. Nardi, A.C. Hauge-Evans, P.M. Jones, and A.J. King Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice Diabetologia 54 2011 1127 1135
81. Z.L. Zhi, A. Kerby, A.J. King, P.M. Jones, and J.C. Pickup Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes Diabetologia 55 2012 1081 1090
82. C.L. Rackham, P.K. Dhadda, A.M. Le Lay, A.J.F. King, and P.M. Jones Pre-culturing islets with adipose-derived Mesenchymal Stromal Cells is an effective strategy for improving transplantation efficiency at the clinically-preferred intraportal site Cell Med. 7 2014 37 47
83. S. Karmaker, T.K. Saha, Y. Yoshikawa, H. Yasui, and H. Sakurai A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex J. Inorg. Biochem. 100 2006 1535 1546
84. J. Wu, and L.J. Yan Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic beta cell glucotoxicity Diabetes Metab. Syndr. Obes. 8 2015 181 188
85. Y.D. Muller, D. Golshayan, D. Ehirchiou, J.C. Wyss, L. Giovannoni, R. Meier, and et al. Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells Diabetes 60 2011 2331 2340
86. M. Yoshioka, T. Kayo, T. Ikeda, and A. Koizumi A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice Diabetes 46 1997 887 894
87. J. Wang, T. Takeuchi, S. Tanaka, S.K. Kubo, T. Kayo, D. Lu, and et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse J. Clin. Invest. 103 1999 27 37
88. D. Ron Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse J. Clin. Invest. 109 2002 443 445
89. C.E. Mathews, S.H. Langley, and E.H. Leiter New mouse model to study islet transplantation in insulin-dependent diabetes mellitus Transplantation 73 2002 1333 1336
90. M. Prentki, and C.J. Nolan Islet beta cell failure in type 2 diabetes J. Clin. Invest. 116 2006 1802 1812
91. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J. Clin. Invest. 106 2000 473 481
92. G.S. Hotamisligil, and B.M. Spiegelman Tumor necrosis factor alpha: a key component of the obesity-diabetes link Diabetes 43 1994 1271 1278
93. H.G. Joost, and A. Schurmann The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models Mamm. Genome 25 2014 401 412
94. J.A. Wali, H.E. Thomas, and A.P. Sutherland Linking obesity with type 2 diabetes: the role of T-bet Diabetes Metab. Syndr. Obes. 7 2014 331 340
95. B. Wang, P.C. Chandrasekera, and J.J. Pippin Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes Curr. Diabetes Rev. 10 2014 131 145
96. P. Lindstrom The physiology of obese-hyperglycemic mice [ob/ob mice] Sci. World J. 7 2007 666 685
97. P. Lindstrom Beta-cell function in obese-hyperglycemic mice [ob/ob Mice] Adv. Exp. Med. Biol. 654 2010 463 477
98. K.P. Hummel, D.L. Coleman, and P.W. Lane The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains Biochem. Genet. 7 1972 1 13
99. M.S. Phillips, Q. Liu, H.A. Hammond, V. Dugan, P.J. Hey, C.J. Caskey, and et al. Leptin receptor missense mutation in the fatty Zucker rat Nat. Genet. 13 1996 18 19
100. A. Pick, J. Clark, C. Kubstrup, M. Levisetti, W. Pugh, S. Bonner-Weir, and et al. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat Diabetes 47 1998 358 364
101. G. Chakraborty, S. Thumpayil, D.E. Lafontant, W. Woubneh, and J.H. Toney Age dependence of glucose tolerance in adult KK-Ay mice, a model of non-insulin dependent diabetes mellitus Lab. Anim. 38 2009 364 368
102. R.A. Koza, K. Flurkey, D.M. Graunke, C. Braun, H.J. Pan, P.C. Reifsnyder, and et al. Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity Metabolism 53 2004 799 808
103. E.H. Leiter, and P.C. Reifsnyder Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes Diabetes 53 Suppl. 1 2004 S4 11
104. J.H. Kim, and A.M. Saxton The TALLYHO mouse as a model of human type 2 diabetes Methods Mol. Biol. 933 2012 75 87
105. E.H. Leiter, M. Strobel, A. O'Neill, D. Schultz, A. Schile, and P.C. Reifsnyder Comparison of two new mouse models of polygenic type 2 diabetes at the jackson laboratory, NONcNZO10Lt/J and TALLYHO/JngJ J. Diabetes Res. 2013 2013 165327
106. K. Kawano, T. Hirashima, S. Mori, and T. Natori OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain Diabetes Res. Clin. Pract. 24 Suppl 1994 S317 S320
107. T.H. Moran Unraveling the obesity of OLETF rats Physiol. Behav. 94 2008 71 78
108. R.S. Surwit, S. Wang, A.E. Petro, D. Sanchis, S. Raimbault, D. Ricquier, and et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice Proc. Natl. Acad. Sci. U. S. A. 95 1998 4061 4065
109. M.S. Winzell, and B. Ahren The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes Diabetes 53 Suppl. 3 2004 S215 S219
110. R.S. Surwit, M.N. Feinglos, J. Rodin, A. Sutherland, A.E. Petro, E.C. Opara, and et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice Metabolism 44 1995 645 651
111. K. Almind, and C.R. Kahn Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice Diabetes 53 2004 3274 3285
112. P. Masiello Animal models of type 2 diabetes with reduced pancreatic beta-cell mass Int. J. Biochem. Cell Biol. 38 2006 873 893
113. C.G. Ostenson, and S. Efendic Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans Diabetes Obes. Metab. 9 Suppl. 2 2007 180 186
114. B. Portha, M.H. Giroix, P. Serradas, M.N. Gangnerau, J. Movassat, F. Rajas, and et al. Beta-cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony Diabetes 50 Suppl. 1 2001 S89 S93
115. F. Homo-Delarche, S. Calderari, J.C. Irminger, M.N. Gangnerau, J. Coulaud, K. Rickenbach, and et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat Diabetes 55 2006 1625 1633
116. S.J. Richardson, A. Willcox, A.J. Bone, A.K. Foulis, and N.G. Morgan Islet-associated macrophages in type 2 diabetes Diabetologia 52 2009 1686 1688
117. S. Bonner-Weir, D.F. Trent, R.N. Honey, and G.C. Weir Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia Diabetes 30 1981 64 69
118. B. Portha, C. Levacher, L. Picon, and G. Rosselin Diabetogenic effect of streptozotocin in the rat during the perinatal period Diabetes 23 1974 889 895
119. T. Irako, T. Akamizu, H. Hosoda, H. Iwakura, H. Ariyasu, K. Tojo, and et al. Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats Diabetologia 49 2006 1264 1273
120. T. Kodera, S. Yamada, Y. Yamamoto, A. Hara, Y. Tanaka, M. Seno, and et al. Administration of conophylline and betacellulin-delta4 increases the beta-cell mass in neonatal streptozotocin-treated rats Endocr. J. 56 2009 799 806
121. A.A. Hardikar, M.S. Karandikar, and R.R. Bhonde Effect of partial pancreatectomy on diabetic status in BALB/c mice J. Endocrinol. 162 1999 189 195
122. S. Bonner-Weir, D.F. Trent, and G.C. Weir Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release J. Clin. Invest. 71 1983 1544 1553
123. F. Martin, E. Andreu, J.M. Rovira, J.A. Pertusa, M. Raurell, C. Ripoll, and et al. Mechanisms of glucose hypersensitivity in beta-cells from normoglycemic, partially pancreatectomized mice Diabetes 48 1999 1954 1961
124. J.C. Jonas, A. Sharma, W. Hasenkamp, H. Ilkova, G. Patane, R. Laybutt, and et al. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes J. Biol. Chem. 274 1999 14112 14121
125. D.T. Finegood, G.C. Weir, and S. Bonner-Weir Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats Am. J. Physiol. 276 1999 E822 7
126. B. Lamothe, A. Baudry, P. Desbois, L. Lamotte, D. Bucchini, P. De Meyts, and et al. Genetic engineering in mice: impact on insulin signalling and action Biochem. J. 335 Pt. 2 1998 193 204
127. E. Araki, M.A. Lipes, M.E. Patti, J.C. Bruning, B. Haag 3rd, R.S. Johnson, and et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene Nature 372 1994 186 190
128. M.E. Patti, X.J. Sun, J.C. Bruening, E. Araki, M.A. Lipes, M.F. White, and et al. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice J. Biol. Chem. 270 1995 24670 24673
129. D.J. Withers, J.S. Gutierrez, H. Towery, D.J. Burks, J.M. Ren, S. Previs, and et al. Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900 904
130. S.F. Previs, D.J. Withers, J.M. Ren, M.F. White, and G.I. Shulman Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo J. Biol. Chem. 275 2000 38990 38994
131. Y. Kido, D.J. Burks, D. Withers, J.C. Bruning, C.R. Kahn, M.F. White, and et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 J. Clin. Invest. 105 2000 199 205
132. R.N. Kulkarni, J.C. Bruning, J.N. Winnay, C. Postic, M.A. Magnuson, and C.R. Kahn Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes Cell 96 1999 329 339
133. M.D. Michael, R.N. Kulkarni, C. Postic, S.F. Previs, G.I. Shulman, M.A. Magnuson, and et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction Mol. Cell 6 2000 87 97
134. M. Bluher, M.D. Michael, O.D. Peroni, K. Ueki, N. Carter, B.B. Kahn, and et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance Dev. Cell 3 2002 25 38
135. J.C. Bruning, M.D. Michael, J.N. Winnay, T. Hayashi, D. Horsch, D. Accili, and et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance Mol. Cell 2 1998 559 569
136. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, J. Lee, and et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat. Med. 11 2005 183 190
137. S.E. Shoelson, J. Lee, and M. Yuan Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 2003 S49 52
138. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, and et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673 1677
139. N. Wijesekara, F.F. Dai, A.B. Hardy, P.R. Giglou, A. Bhattacharjee, V. Koshkin, and et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion Diabetologia 53 2010 1656 1668
140. M. Freemark, I. Avril, D. Fleenor, P. Driscoll, A. Petro, E. Opara, and et al. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance Endocrinology 143 2002 1378 1385
141. H.C. Barbosa-Sampaio, B. Liu, R. Drynda, A.M. Rodriguez de Ledesma, A.J. King, J.E. Bowe, and et al. Nupr1 deletion protects against glucose intolerance by increasing beta cell mass Diabetologia 56 2013 2477 2486
142. P.E. MacDonald, J.W. Joseph, D. Yau, J. Diao, Z. Asghar, F. Dai, and et al. Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase Endocrinology 145 2004 4078 4083
143. K. Kim, C.M. Oh, M. Ohara-Imaizumi, S. Park, J. Namkung, V.K. Yadav, and et al. Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state Endocrinology 156 2015 444 452
144. J.C. McNelis, Y.S. Lee, R. Mayoral, R. van der Kant, A.M. Johnson, J. Wollam, and et al. GPR43 potentiates beta cell function in obesity Diabetes 64 2015 3203 3217
145. K. Chen, A. Jih, S. Kavaler, W.S. Lagakos, D. Oh, S. Watkins, and et al. Dual actions of a novel bifunctional compound to lower glucose in mice with diet-induced insulin resistance Am. J. Physiol. Endocrinol. Metab. 309 2015 E293 E301
146. M. Nixon, D.J. Wake, D.E. Livingstone, R.H. Stimson, C.L. Esteves, J.R. Seckl, and et al. Salicylate downregulates 11beta-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization Diabetes 61 2012 790 796
147. A. Al-Romaiyan, A.J. King, S.J. Persaud, and P.M. Jones A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro Phytother. Res. 27 2013 1006 1011
148. B. Liu, Z. Hassan, S. Amisten, A.J. King, J.E. Bowe, G.C. Huang, and et al. The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis Diabetologia 56 2013 2467 2476
149. M. Koyama, R. Wada, H. Mizukami, H. Sakuraba, H. Odaka, H. Ikeda, and et al. Inhibition of progressive reduction of islet beta-cell mass in spontaneously diabetic Goto-Kakizaki rats by alpha-glucosidase inhibitor Metabolism 49 2000 347 352
150. L. Ladriere, F. Malaisse-Lagae, J. Fuhlendorff, and W.J. Malaisse Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats Eur. J. Pharmacol. 335 1997 227 234
151. N.H. Greig, H.W. Holloway, K.A. De Ore, D. Jani, Y. Wang, J. Zhou, and et al. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations Diabetologia 42 1999 45 50
152. M. Szayna, M.E. Doyle, J.A. Betkey, H.W. Holloway, R.G. Spencer, N.H. Greig, and et al. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats Endocrinology 141 2000 1936 1941
153. J. Sturis, C.F. Gotfredsen, J. Romer, B. Rolin, U. Ribel, C.L. Brand, and et al. GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics Br. J. Pharm. 140 2003 123 132
154. C.A. Lindamood, and J.R. Taylor Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists Clin. Ther. 37 2015 483 493
155. C. Tourrel, D. Bailbe, M. Lacorne, M.J. Meile, M. Kergoat, and B. Portha Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4 Diabetes 51 2002 1443 1452
156. A.A. Young, B.R. Gedulin, S. Bhavsar, N. Bodkin, C. Jodka, B. Hansen, and et al. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta) Diabetes 48 1999 1026 1034
157. N. Ogawa, J.F. List, J.F. Habener, and T. Maki Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4 Diabetes 53 2004 1700 1705
158. C. Tourrel, D. Bailbe, M.J. Meile, M. Kergoat, and B. Portha Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age Diabetes 50 2001 1562 1570
159. A.K. Lai, and A.C. Lo Animal models of diabetic retinopathy: summary and comparison J. Diabetes Res. 2013 2013 106594
160. B. Betz, and B.R. Conway Recent advances in animal models of diabetic nephropathy Nephron Exp. Nephrol. 126 2014 191 195
161. F.C. Brosius 3rd, C.E. Alpers, E.P. Bottinger, M.D. Breyer, T.M. Coffman, S.B. Gurley, and et al. Mouse models of diabetic nephropathy J. Am. Soc. Nephrol. 20 2009 2503 2512
162. T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, and et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy J. Am. Soc. Nephrol. 18 2007 539 550
163. Y. Kanetsuna, K. Takahashi, M. Nagata, M.A. Gannon, M.D. Breyer, R.C. Harris, and et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice Am. J. Pathol. 170 2007 1473 1484
164. P.D. O'Brien, S.A. Sakowski, and E.L. Feldman Mouse models of diabetic neuropathy ILAR J. 54 2014 259 272
165. F. Gao, and Z.M. Zheng Animal models of diabetic neuropathic pain Exp. Clin. Endocrinol. Diabetes 122 2014 100 106
166. D.A. Andersson, M.R. Filipovic, C. Gentry, M. Eberhardt, N. Vastani, A. Leffler, and et al. Streptozotocin stimulates TRPA1 directly: involvement of peroxynitrite J. Biol. Chem. 290 2015 15185 15196
167. R. Sladek, G. Rocheleau, J. Rung, C. Dina, L. Shen, D. Serre, and et al. A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 2007 881 885
168. R.D. Cox, and C.D. Church Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity Dis. Models Mech. 4 2011 155 164
169. G. da Silva Xavier, E.A. Bellomo, J.A. McGinty, P.M. French, and G.A. Rutter Animal models of GWAS-identified type 2 diabetes genes J. Diabetes Res. 2013 2013 906590
170. S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, and et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat. Genet. 38 2006 320 323
171. L.J. Scott, K.L. Mohlke, L.L. Bonnycastle, C.J. Willer, Y. Li, W.L. Duren, and et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 2007 1341 1345
172. G. da Silva Xavier, A. Mondragon, G. Sun, L. Chen, J.A. McGinty, P.M. French, and et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice Diabetologia 55 2012 2667 2676
173. S.F. Boj, J.H. van Es, M. Huch, V.S. Li, A. Jose, P. Hatzis, and et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand Cell 151 2012 1595 1607
174. T.J. Nicolson, E.A. Bellomo, N. Wijesekara, M.K. Loder, J.M. Baldwin, A.V. Gyulkhandanyan, and et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants Diabetes 58 2009 2070 2083
175. G. Mingrone, S. Panunzi, A. De Gaetano, C. Guidone, A. Iaconelli, L. Leccesi, and et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes N. Engl. J. Med. 366 2012 1577 1585
176. F. Andreelli, C. Amouyal, C. Magnan, and G. Mithieux What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab. 35 2009 499 507
177. L. Sjostrom, A.K. Lindroos, M. Peltonen, J. Torgerson, C. Bouchard, B. Carlsson, and et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N. Engl. J. Med. 351 2004 2683 2693
178. H. Buchwald, Y. Avidor, E. Braunwald, M.D. Jensen, W. Pories, K. Fahrbach, and et al. Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
179. H. Buchwald, R. Estok, K. Fahrbach, D. Banel, M.D. Jensen, W.J. Pories, and et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am. J. Med. 122 2009 248 256 e5
180. L. Sjostrom, M. Peltonen, P. Jacobson, C.D. Sjostrom, K. Karason, H. Wedel, and et al. Bariatric surgery and long-term cardiovascular events JAMA 307 2012 56 65
181. P.R. Schauer, D.L. Bhatt, J.P. Kirwan, K. Wolski, S.A. Brethauer, S.D. Navaneethan, and et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes N. Engl. J. Med. 370 2014 2002 2013
182. F. Rubino, and J. Marescaux Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann. Surg. 239 2004 1 11
183. D.P. Yin, K.L. Boyd, P.E. Williams, N.N. Abumrad, and D.H. Wasserman Mouse models of bariatric surgery Curr. Protoc. Mouse Biol. 2012 2012
184. F. Seyfried, R. le, C.W. oux, and M. Bueter Lessons learned from gastric bypass operations in rats Obes. Facts 4 Suppl. 1 2011 3 12
185. A. Lindqvist, P. Spegel, M. Ekelund, E. Garcia Vaz, S. Pierzynowski, M.F. Gomez, and et al. Gastric bypass improves beta-cell function and increases beta-cell mass in a porcine model Diabetes 63 2014 1665 1671
186. S. Salinari, C. Debard, A. Bertuzzi, C. Durand, P. Zimmet, H. Vidal, and et al. Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance PLoS One 8 2013 e56258